Preparing For The Third Phase Of Clinical Trials: Russia

Preparing for the third phase of clinical trials: Russia

Oxford-AstraZeneca vaccine candidate has received regulatory approval to conduct part of a Phase III trial of its potential COVID-19 vaccine, AZD1222, in Russia, a filing in the Russian registry of clinical trials showed on Frida, reported Reuters.

 Preparing For The Third Phase Of Clinical Trials: Russia-TeluguStop.com

The trial will involve 150 participants and will be handled by four medical facilities in St.Petersburg and Moscow, the registry filing, showed.

Meanwhile, the European Union has agreed to buy at least 300 million doses of AstraZeneca’s potential Covid-19 vaccine in its first such advance purchase deal, which could weaken plans led by the World Health Organisation for a global approach.

The European Commission, which is negotiating on behalf of all 27 EU member states, said the deal included an option to purchase 100 million additional doses from the British drugmaker should its vaccine prove safe and effective.

.

Follow Us on Facebook Follow Us on WhatsApp Follow Us on Twitter